HAUPPAUGE, N.Y., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced the submission to the U ...
Thinly traded nano cap Chembio Diagnostics (CEMI-13.1%) is down on modestly higher volume, only 148K shares, on the heels of an update on its U.S. marketing application for its DPP HIV-Syphilis Assay ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results